PDCD1 and endocrine system disorder: In the process of exerting respective therapeutic effects, the side effects of anti-PD-1/PD-L pathway are mostly reported as dermatologic toxicity, gastrointestinal toxicity, endocrinopathies, pneumonitis and rheumatologic toxicity (14).